|
|
|
|
@ -45,4 +45,7 @@ date:: [[2023/12]]
|
|
|
|
|
- Target protocol implementation: end 2024 or early 2025 (rainy season permitting) for implementation.
|
|
|
|
|
- Standalone; not part of the Safety and Effectiveness clinical trial
|
|
|
|
|
- Protocol
|
|
|
|
|
- January: Draft primary and secondary research questions aligned to government/programme decision
|
|
|
|
|
- January: Draft primary and secondary research questions aligned to government/programme decision requirements
|
|
|
|
|
- Full draft protocol Q1 2024 (after formative research)
|
|
|
|
|
- 3 dose regimen
|
|
|
|
|
- Continue to include – potential to inform future MDA degi
|
Borja Robert
12 months ago